Pure Global

HYALO4 Control cream - Cation-active surfactant dressing - ARTG 353298

Access comprehensive regulatory information for HYALO4 Control cream - Cation-active surfactant dressing in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 353298 and sponsored by Ainscorp Pty Ltd, manufactured by Fidia Farmaceutici SPA in Italy. The device registration started on January 19, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 353298
Class III
HYALO4 Control cream - Cation-active surfactant dressing
ARTG ID: 353298
Good Name: Ainscorp Pty Ltd - HYALO4 Control cream - Cation-active surfactant dressing
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

For the management of skin lesions, especially those at high risk of infection. In particular, it is intended to cover acute and chronic wounds (first and second degree burns, vascular and metabolic ulcers and pressure sores) and to provide a moist microbe-free wound environment. Hyalo4 Control can be used on non-infected wounds to help in preventing infection and, following successful treatment of infected wounds, to help prevent the reoccurrence of infection.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
353298
Start Date
January 19, 2021
Effective Date
January 19, 2021
Sponsor
Manufacturer
Country
Italy
Address
Via Ponte Della Fabbrica 3/A, Abano Terme, Padova, 35031